The Prognostic Role of BRAF Mutation in Metastatic Colorectal Cancer Receiving Anti-EGFR Monoclonal Antibodies: A Meta-Analysis

BACKGROUND: BRAF mutation has been investigated as a prognostic factor in metastatic colorectal cancer (mCRC) undergoing anti-EGFR monoclonal antibodies (moAbs), but current results are still inconclusive. The aim of this meta-analysis was to evaluate the relationship between BRAF mutation status an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Zi-Xu, Wang, Xiao-Yan, Qin, Qi-Yuan, Chen, De-Feng, Zhong, Qing-Hua, Wang, Lei, Wang, Jian-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679027/
https://www.ncbi.nlm.nih.gov/pubmed/23776587
http://dx.doi.org/10.1371/journal.pone.0065995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679027/
https://www.ncbi.nlm.nih.gov/pubmed/23776587
http://dx.doi.org/10.1371/journal.pone.0065995

Ejemplares similares